Recommendations for follow-up of colorectal cancer survivors

Clin Transl Oncol. 2019 Oct;21(10):1302-1311. doi: 10.1007/s12094-019-02059-1. Epub 2019 Feb 14.

Abstract

Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number of patients who survive for prolonged periods of time. In addition, despite recurrences, improved survival following metastasis resection is likewise on the rise. This underscores the importance of carrying out follow-up programmes even in low-risk patients for the early detection of recurrence. The main objective of this article is to provide a set of recommendations for optimising the follow-up of CRC survivors as well as for managing the sequelae that result from either pharmacological or surgical treatment.

Keywords: Cancer survivors; Care coordination; Monitoring; Quality of life; Surveillance; Treatment sequelae.

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Cancer Survivors*
  • Carcinoembryonic Antigen / analysis
  • Colonic Neoplasms / diagnosis*
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy
  • Colonoscopy
  • Continuity of Patient Care*
  • Female
  • Humans
  • Liver Neoplasms / diagnostic imaging
  • Liver Neoplasms / secondary
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / secondary
  • Male
  • Neoplasm Recurrence, Local / diagnosis*
  • Neoplasm Recurrence, Local / prevention & control
  • Neoplasm Staging
  • Oxaliplatin / adverse effects
  • Patient Care Team
  • Population Surveillance*
  • Postoperative Complications
  • Primary Prevention
  • Radiotherapy / adverse effects
  • Rectal Neoplasms / diagnosis*
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / therapy
  • Secondary Prevention
  • Sexual Dysfunction, Physiological / etiology
  • Time Factors

Substances

  • Antineoplastic Agents
  • Carcinoembryonic Antigen
  • Oxaliplatin